Tuesday, February 5, 2008

Endologix Comments on NEJM Study Highlighting Advantages of Minimally Invasive Endovascular Repair

IRVINE, Calif.--(HSMN NewsFeed)--Endologix, Inc. (Nasdaq:ELGX ), developer and manufacturer of the Powerlink® System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today noted a study published in the January 31, 2008 New England Journal of Medicine comparing results of AAA repair following open surgery and endovascular repair. Based on a review of 45,660 Medicare discharges, the study authors found that significantly more patients were discharged to home following endovascular repair, and that the laparotomy necessary to perform open repair carried its own risk for re-hospitalizations due to serious medical problems, such as abdominal wall hernia and bowel resection.

full article >> http://salesandmarketingnetwork.com/news_release.php?ID=2023075

No comments: